Tests diosmin and hesperidin as add-on treatment for rheumatoid arthritis
Tests a combination of diosmin and hesperidin alongside usual care in adults with rheumatoid arthritis.
Plain-language title generated from the registry record
Registry title: Effect of Diosmin and Hesperidin in Treatment of Patients With Rheumatoid Arthritis
Key facts
- Where
- Alexandria, EgyptSee the site
- Phase
- Phase 3
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 19 and 65 years old?
Source: NCT05756179, who can take part
Where in Egypt
- Alexandria University HospitalAlexandria, EgyptTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Alexandria University
- Trial code
- NCT05756179
- Record updated
- 25 April 2025
- Original description
Evaluating the effect of the flavonoids combination (diosmin and hesperidin) as adjuvant therapy on patients with rheumatoid arthritisRead full original descriptionShow less
Clinical Study Evaluating the Effect of Diosmin and Hesperidin in Treatment of Patients With Rheumatoid Arthritis
Evaluating the effect of the flavonoids combination (diosmin and hesperidin) as adjuvant therapy on patients with rheumatoid arthritis
Inclusion: Patients with mild to moderate disease activity; Patient age must be more than 18 years.
Exclusion: Patients with liver, renal impairment or any other inflammatory diseases; Pregnant and lactating females; Patients on TNF-α (tumor necrosis factor- α) or IL-1β (interleukin-1β) antagonists.